Advent Life Sciences

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

1 Sept 2025

Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

Cyted Health develops minimally invasive diagnostic tests for gastrointestinal disease, combining cell collection devices with molecular biomarkers to detect conditions earlier.

Advent Life Sciences

- Health
1(12 months)
adventls.com
Update Information

More venture news

Partly
24 Jun 2026
Partly lands £40m Series B led by DST Global Partners for its AI foundation model for the automotive repair supply chain
Series BSupply Chain
Wordsmith AI
3 Jun 2026
Wordsmith raises £55m Series B from Highland Europe and Index Ventures to bring end-to-end operations platform to in-house legal teams
Series BLegal
Orbital Industries
28 May 2026
Orbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model
Series BAI

Advent Life Sciences

Investment Portfolio

Cyted Health raises £32.5m Series B led by British Business Bank, EQT and Advent Life Sciences to expand gastrointestinal diagnostics

More venture news

Partly lands £40m Series B led by DST Global Partners for its AI foundation model for the automotive repair supply chain

Wordsmith raises £55m Series B from Highland Europe and Index Ventures to bring end-to-end operations platform to in-house legal teams

Orbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model